LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
LipUm has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
LipUm's investors include Almi Invest, Horizon Europe, EISMEA, Eurostars, Flerie Invest.
LipUm is headquartered in Umeå, Sweden.
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
LipUm is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LipUm — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/lipum. Accessed November 13, 2026.
VCBacked. (2026). LipUm — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/lipum
{{cite web |title=LipUm — Funding & Investors |url=https://www.vcbacked.co/company/lipum |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at LipUm? Request a listing update